3-D Matrix, Ltd. (TYO:7777)

Market Cap	48.24B +236.5%
Revenue (ttm)	9.22B +38.4%
Net Income	1.25B
EPS	9.63
Shares Out	127.97M
PE Ratio	39.13
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	560,600
Open	377.00
Previous Close	377.00
Day's Range	373.00 - 386.00
52-Week Range	144.00 - 793.00
Beta	0.97
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 11, 2026

About 3-D Matrix

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 114
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7777

Financial Performance

In fiscal year 2025, 3-D Matrix's revenue was 6.93 billion, an increase of 51.13% compared to the previous year's 4.59 billion. Losses were -2.50 billion, 880.8% more than in 2024.